Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


European Commission May Pursue More Antitrust Actions Against Pharma

This article was originally published in The Pink Sheet Daily

Executive Summary

The EC is scrutinizing pharma practices that may delay generic entry and advocating changes in the patent system.

You may also be interested in...

EMA To Share Generics Data To Speed Access, But Pitfalls Remain

The EMA has announced that it is ready to share information on generic marketing authorizations with other regulators, which should speed market access, but industry remains concerned about patent linkage and discriminatory regulatory standards.

EU Commission Misses Chance To Lead On Drug Patent Settlements

The European Commission has published its annual report on the monitoring of patent settlements in Europe but has again failed to offer pharma firms the guidance and legal certainty they need.

EU/U.S. Trade Pact Talks May Stumble Over Drug Regulation, Affordability

The EU Parliament’s health committee has highlighted regulatory pitfalls within TTIP, while civil society elements decry its lack of transparency and potential impact on health care affordability.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts